Hutchison China Meditech Limited Director's Share Dealing (4283P)

TIDMHCM

RNS Number : 4283P

Hutchison China Meditech Limited

31 August 2017

Director's Share Dealing

London: Thursday, August 31, 2017: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notifications that Mr Simon To, Executive Director and Chairman, through Dynamic Drive Limited, a person closely associated with Mr To, purchased a total of 14,748 American Depositary Shares of the Company ("ADSs", each representing one half of one ordinary share of US$1.00 each in the capital of Chi-Med) on August 28 and 29, 2017 at an average price of US$24.40 per ADS. Dynamic Drive Limited is controlled by the trustee of Dynamic Drive Trust (the "DDT") which has been established for the benefit of Mr To's family members, of which Mr To is the settlor.

Following the above purchases, Mr To is interested in 133,237 ADSs (in DDT and Wencheng Trust of which his family members are the beneficiaries) and 180,000 Ordinary Shares (including the holding of 78,000 Ordinary Shares in DDT of which his family members are the beneficiaries), representing in aggregate approximately 0.41% of the current issued share capital of Chi-Med.

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 
 1      Details of the person discharging managerial responsibilities/person closely associated 
-----  --------------------------------------------------------------------------------------------------------------- 
  a)     Name                                  Dynamic Drive Limited 
-----  ------------------------------------  ------------------------------------------------------------------------- 
 2      Reason for the notification 
-----  --------------------------------------------------------------------------------------------------------------- 
  a)     Position/status                       Person closely associated with Mr Simon To, Executive Director and 
                                               Chairman. Dynamic Drive 
                                               Limited is controlled by the trustee of Dynamic Drive Trust which has 
                                               been established for 
                                               the benefit of Mr To's family members, of which Mr To is the settlor. 
-----  ------------------------------------  ------------------------------------------------------------------------- 
  b)     Initial notification/Amendment        Initial notification 
-----  ------------------------------------  ------------------------------------------------------------------------- 
 3      Details of the issuer, emission allowance market participant, auction platform, auctioneer 
         or auction monitor 
-----  --------------------------------------------------------------------------------------------------------------- 
  a)     Name                                  Hutchison China MediTech Limited 
-----  ------------------------------------  ------------------------------------------------------------------------- 
  b)     LEI                                   2138006X34YDQ6OBYE79 
-----  ------------------------------------  ------------------------------------------------------------------------- 
 4      Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
         each type of transaction; (iii) each date; and (iv) each place where transactions have been 
         conducted 
-----  --------------------------------------------------------------------------------------------------------------- 
  a)     Description of the financial          ADS each representing one half of one Ordinary Share of US$1.00 
         instrument, type of instrument         ADS ISIN: US44842L1035 
         Identification code 
-----  ------------------------------------  ------------------------------------------------------------------------- 
  b)     Nature of the transaction             Acquisition of a total of 14,748 ADSs in the name of Dynamic Drive 
                                               Limited which holds the 
                                               ADSs for a family trust (Dynamic Drive Trust) of which Mr To is the 
                                               settlor on August 28 and 
                                               29, 2017 at an average price of US$24.40 per ADS. 
-----  ------------------------------------  ------------------------------------------------------------------------- 
 
 c)     Price(s) and volume(s)                             Price(s)                             Volume(s) 
-----  ------------------------------------  ------------------------------------  ----------------------------------- 
                                      US$24.47                                                    5,554 
  -------------------------------------------------------------------------------  ----------------------------------- 
                                      US$24.36                                                    9,194 
  -------------------------------------------------------------------------------  ----------------------------------- 
 
  d)     Aggregated information                Aggregated volume: 14,748 ADSs 
          - Aggregated volume                   Price information: US$24.40 
          - Price 
-----  ------------------------------------  ------------------------------------------------------------------------- 
  e)     Date of the transaction               2017-08-28 - acquisition of 5,554 ADSs 
                                                2017-08-29 - acquisition of 9,194 ADSs 
-----  ------------------------------------  ------------------------------------------------------------------------- 
  f)     Place of the transaction              Nasdaq Stock Market 
-----  ------------------------------------  ------------------------------------------------------------------------- 
 

About Chi-Med

Chi-Med is an innovative biopharmaceutical company which researches, develops, manufactures and sells pharmaceuticals and healthcare products. Its Innovation Platform, Hutchison MediPharma Limited, focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures, markets, and distributes prescription drugs and consumer health products in China.

Chi-Med is majority owned by the multinational conglomerate CK Hutchison Holdings Limited ("CK Hutchison") (SEHK: 0001). For more information, please visit: www.chi-med.com.

CONTACTS

 
Investor Enquiries 
Mark Lee, 
 SVP Corporate Finance & Development       [phone] 
 
U.K. & International Media Enquiries 
Anthony Carlisle, Citigate Dewe Rogerson   [phone] (Mobile)   [e-mail] 
 
U.S. Based Media Enquiries 
Brad Miles, BMC Communications             [phone] (Mobile)  [e-mail] 
Susan Duffy, BMC Communications            [phone] (Mobile)  [e-mail] 
 
Investor Relations 
Matt Beck, The Trout Group                 [phone] (Mobile)  [e-mail] 
David Dible, Citigate Dewe Rogerson        [phone] (Mobile)   [e-mail] 
 
Panmure Gordon (UK) Limited 
Richard Gray / Andrew Potts                [phone] 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLIFIATLILVID

(END) Dow Jones Newswires

August 31, 2017 05:15 ET (09:15 GMT)